Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Neutropenia is one of the most common and serious adverse effects of chemotherapy and is thus an important issue for researchers and clinicians who are working to improve the QOL of patients with ...

A prospective study in 138 patients with a variety of cancers treated with different regimens evaluated the effects on QOL of chemotherapy delays due to neutropenia, which are frequently used in ...

Medically reviewed by Marla Anderson, MD "Chemo fever" is a term used to describe a fever caused by chemotherapy treatment, ...

Patients undergoing chemotherapy are particularly prone to developing neutropenia while their cell counts replenish. Dr Paul Cornes, consultant oncologist, Bristol NHS Foundation Trust, said ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study. Using data from ...

Patients undergoing chemotherapy are particularly prone to developing neutropenia while their cell counts replenish. Dr Paul Cornes, consultant oncologist, Bristol NHS Foundation Trust, said ...

Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate ...

Tevimbra approved for HER2-negative gastric or gastroesophageal junction adenocarcinoma with PD-L1 expression, in combination with chemotherapy. Phase 3 trial showed Tevimbra improved median overall ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators ...